Real‐world direct oral anticoagulant experience in atrial fibrillation: falls risk and low dose anticoagulation are predictive of both bleeding and stroke risk

R Brook, O Aswapanyawongse, M Tacey… - Internal medicine …, 2020 - Wiley Online Library
Background Clinical trials have demonstrated that direct oral anticoagulants (DOAC) are
non‐inferior to vitamin K antagonist for stroke prevention in non‐valvular atrial fibrillation …

Evidence and uncertainties in the management of atrial fibrillation in older persons

P Alboni, M Bo, S Fumagalli, F Vetta, G Isaia, E Brunetti… - Minerva Medica, 2022 - iris.unito.it
Introduction: Atrial fibrillation (AF) is the most common cardiac sustained arrhythmia, whose
incidence and prevalence increase with age, representing a significant burden for health …

[PDF][PDF] Evidence and uncertainties in the management of atrial fibrillation in older persons

M Medica - iris.unito.it
ABSTRACT INTRODUCTIONː Atrial fibrillation (AF) is the most common cardiac sustained
arrhythmia, whose incidence and prevalence increase with age, representing a significant …

[引用][C] Anticoagulation in elderly patients with nonvalvular atrial fibrillation: a balancing act

AM Fawzy, GYH Lip - Heart Rhythm, 2019 - heartrhythmjournal.com
Atrial fibrillation (AF) is a major global health burden because of its rising prevalence and
associated complications such as stroke and mortality. 1 In the 2010 Global Burden of …

[引用][C] Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation

AM Fawzy, B Olshansky… - American heart journal, 2019 - pubmed.ncbi.nlm.nih.gov
Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for
patients with atrial fibrillation Frailty and multi-morbidities should not govern oral …